Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-03-25
2009-06-09
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S044000
Reexamination Certificate
active
07544681
ABSTRACT:
Novel chemical conjugates of psychotropic drugs and organic acids, uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents, and their syntheses are disclosed. The organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity.
REFERENCES:
patent: 2914528 (1959-11-01), Craig
patent: 2944053 (1960-07-01), Edgerton
patent: 2969358 (1961-01-01), Cusic
patent: 3966930 (1976-06-01), Buus et al.
patent: 5525727 (1996-06-01), Bodor
patent: 5994392 (1999-11-01), Shashoua
patent: 6569853 (2003-05-01), Borisy et al.
patent: 829 246 (1960-03-01), None
patent: WO 02/43652 (2002-06-01), None
patent: WO 03/026563 (2003-03-01), None
Nordenberg et al. “Effects of Psychotropic Drugs on Cell Proliferation and Differentiation”, Biochemical Pharmacology, 58: 1229-1236, 1999.
Fingl et al. “General Principles”, The Pharmacological Basis of Therapeutics, Chap.1: 1-46, 1975.
Budavari et al. “The Merck Index”, Merck & Co., USA, 12th Ed., 1996. P.THER-8, First Col., 6th Line From the Bottom, 2nd Col., Line 13.
Budavari et al. “The Merck Index”, Merck & Co., USA, 12th Ed, 1996. p. 1260, § 1.
Budarari et al. “The Merck Index”, Merck & Co., USA, 12th Ed., 1996. p. 1246, Last §.
Scriba et al “Anticonvulsant Activity of Phenytoin-Lipid Conjugates, A New Class of Phenytoin Prodrugs”—Journal of Pharmaceutical Pharamacology, 47: 197-203, 1996.
Scriba “ Phenytoin-Lipid Conjugates as Potential Prodrugs of Phenytoin”, Archiv der Pharmazie, VCH—Verlagsgesellschaft MBH, Weinheim, DE, 326(8): 477-481, 1993.
Capasso et al. “Anticonvulsive Activity of a New GABA Mimetic Drug”, European Neuropsychopharmacology, 7: 57-63, 1997.
Geyer et al. “Animal Behavior Models of the Mechanisms Underlying Antipsychotic Atypicality”, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27: 1071-1079, 2003.
Köpf-Maier et al. “An Organoid Culture Assay (OCA) for Determining the Drug Sensitivity of human Tumors”, Int. J. Cancer, 51: 99-107, 1992.
Lloyd et al. “The Potential Use of GABA Agonists in Psychiatric Disorders: Evidence From Studies With Progabide in Animal Models and Clinical Trials”, Pharmacology, Biochemistry & Behavior, 18: 957-966, 1983.
McCaffrey et al. “A Rapid Fluorometric DNA Assay for the Measurement of Cell Density and Proliferation In Vitro”, In Vitro Cellular Development Biology, 24(3): 247-252, 1988. Abstract.
Nicoletti et al. “A Rapid and Simple Method for Measuring Thymocyte Apoptosis by Propidium lodide Staining and Flow Cytometry”, Journal of Immunological Methods, 139: 271-279, 1991.
Quadri et al. “Effects of Centrally Acting Drugs on Serum Prolactin Levels in Rhesus Monkeys”, Neuroendocrinology, 27(3-4): 136-147, 1978. Abstract.
Pouzet et al. “Effects of the 5-HT7 Receptor Antagonist SB-258741 in Animal Models for Schizophrenia”, Pharmacology, Biochemistry and Behavior, 71: 655-665, 2002.
Shalitin et al. “The Effect of Angiotensin II on Myosin Heavy Chain Expression in Cultured Myocardial Cells”, In Vitro Cellular Development Biology—Animal, 32: 573-578, 1996.
Toth “A Novel Chemical Approach to Drug Delivery: Lipidic Amino Acid Conjugates”, Journal of Drug Targeting, 2: 217-239, 1994.
Wolffe “Transcriptional Control. Sinful Repression”, Nature, 387: 16017, 1997.
Worms et al. “Dopamine-Like Activities of An Aminopyridazinde Derivative, CM 30366: A Behavioural Study”, Naunyn-Schmiedeberg's Archives of Pharmacology, 334: 246-252, 1986.
Gil-Ad Irit
Nudelman Abraham
Rephaeli Ada
Weizman Abraham
Bar-Ilan University
Coleman Brenda L
Ramot At Tel Aviv University Ltd.
LandOfFree
Conjugated psychotropic drugs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugated psychotropic drugs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugated psychotropic drugs and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078293